Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 3,215.70 | 1,559.36 | 2,768.04¢ | 14.3 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 3,385.89 | 1,622.17 | 2,863.37¢ | 13.8 | 4.0 | +3% | n/a | 0.0% |
31-Dec-27 | 3,555.02 | 1,652.88 | 2,808.36¢ | 14.1 | n/a | -2% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
GlaxoSmithKline reportedly running the ruler ove... | 04-Aug-2017 | ShareCast |
Contracting | 06-Dec-2007 | Washington Post |
United Therapeutics Shares Soar on FDA Report | 02-Nov-2007 | Washington Post |
Study Raises Questions For United Therapeutics | 27-Feb-2007 | Washington Post |
Currency | US Dollars |
Share Price | $ 396.50 |
Change Today | $ -7.30 |
% Change | -1.81 % |
52 Week High | $410.00 |
52 Week Low | $274.70 |
Volume | 650,182 |
Shares Issued | 43.56m |
Market Cap | $17,273m |
RiskGrade | 132 |
Strong Buy | 6 |
Buy | 4 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 15 |
Time | Volume / Share Price |
16:00 | 133,522 @ $396.50 |
15:59 | 100 @ $396.24 |
15:59 | 100 @ $396.30 |
15:59 | 155 @ $396.30 |
15:59 | 100 @ $396.45 |
You are here: research